TherapeuticsMD | TXMD - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1000 2026-03
CSL USD 482.13M 93.87M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Novo Nordisk DKK 4.44B 3.99B 2025-06
Pfizer USD 5.7B 13M 2026-03
TherapeuticsMD USD 11K 0 2023-09